Dow Up0.11% Nasdaq Up0.50%

Jazz Pharmaceuticals Public Limited Company (JAZZ)

-NasdaqGS
162.92 0.21(0.13%) Aug 29, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 291,230   246,919   235,774   232,160  
Cost of Revenue30,692  30,924  25,643  24,252  
Gross Profit 260,538   215,995   210,131   207,908  
Operating Expenses
Research Development20,090  18,109  13,809  16,814  
Selling General and Administrative100,556  106,363  81,299  74,970  
Non Recurring32,806  127,000   -  (4,000)
Others32,795  31,182  20,524  19,564  
Total Operating Expenses186,247  282,654   -  107,348  
Operating Income or Loss 74,291   (66,659) 94,499   100,560  
Income from Continuing Operations
Total Other Income/Expenses Net74  123  (969)(614)
Earnings Before Interest And Taxes74,365  (66,536)93,530  99,946  
Interest Expense11,429  10,076  6,173  6,202  
Income Before Tax62,936  (76,612)87,357  93,744  
Income Tax Expense19,350  17,027  32,064  18,335  
Minority Interest73  989   -   -  
Net Income From Continuing Ops43,659  (92,650)55,293  79,158  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 43,659   (92,650) 55,293   75,409  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 43,659   (92,650) 55,293   75,409  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.